UK Patent Office

UK Patent Office. How to Prepare a UK Patent Application, State House 66-71, High Holbom, London, WCl. 

Server (www.patent.womplex.ibm.com) which gives access to over 26 years of US patent specifications the UK Patent Office (www.patent.gov.nk) the US Patent and Trademark Office (www.uspto.gov) and Biotechnology and US patents (www.nal.usda.gov/bic/Biotech-Patents). 

Some national offices such as the UK Patent Office (http // www.patent.gov.uk/) have plans to extend the electronic archive with scanned images of British patents these will need to be processed for optical character recognition, in order to make the text within searchable without such processing, the images are not identified by searching methods. 

UK Patent Office. What is a Patent (2006). Available http //www.patent.gov.uk/ patent/ definition.htm. Accessed 20 July 2006. 

UK Patent Office (2005). Examination Guidelines for Patent Applications relating to Biotechnological Inventions in the UK Patent Office. 

Japane.se Agency of Industrial Science and Technology (1983) Pat. Appl. No. 2 129825, UK Patent Office, August 24, 1983. 

Following this decision, the UK Patent Office has issued new guidelines on patents for computer programs36. 

These can be found on the UK patent office web site, www.patent.gov.uk. 

Parkes A (1857) Application for British patent 1856. In Patents for inventions. UK Patent office, p 255... 

WPINDEX Derwent Information, Ltd., UK international patents biblio. 13 mio patent offices, patent docu- ments Thomson Inc. online commercial weekly www.derwent.- com/... 

Applications can either be made separately in every country where protection is sought - a process that is both costly and time consuming - or imder one of the international conventions that exist. The one most relevant to UK applicants is the European Patent Convention (EPC). Under this, an application is made to the European Patent Office in Munich, designating the signatory states in which a patent is required. This replaces the procedures in the National Patent Offices and results, upon acceptance of the application, in separate national patents in each of the designated states. All European Community Member States are parties. It should be noted that there is no single patent available for all the European Community countries a so-called Community Patent is envisaged for the future, but is still some way off. 

Hie European Patent office ESPACE scries of CD-ROM products are ESPACE-EP. ESPACE-FiRST. ESPACE-UK. ESPACE-WORLD. and ESPACE-ACCESS. 

C-24] Fritz, R., The Path of Least Resistance for Managers, Berret-Koehler, California, 1999 [C-25] Allan, D., Kingdon, M., Musin, K., Rudkin, D., What If, Capstone, Oxford, 1999 [C-26] Latham, D., Bradbeer, A.,/. Soc. Dyers d. Colourists, 110,1994, 58 [C-27] UK Patents Act 2004, The Stationery Office, London, www.patent.gov.uk [C-28] IPR Module, MSc in Chemical Technology and Management, University of Strathclyde, 2000... 

The desk top computer, via the Internet and such US compilations as delphion.com, or the various national patent office compilations, notably www.patent.gov.uk/, esp cenet and www.uspto.gov/patft/index.html/, provides access to patents, greatly aided in the author s case by the British Library paper and electronic systems. Patents provide useful literature references and access to the inventors basic thinking, right or wrong Patents, the author has found, are full of mistakes, inconsistencies and contradictions, which enable the reader to learn by comparison, and to sort out the quintessential information. See Appendix C, for an elementary patent search technique via the US Patent Office. 

Tarling, S. E. (1992). Declaration to European Patent Office regarding action of the Opposition Division dated 23rd April 1992 in relation to EP 0 091 787. [305] Tarling, S.E. (2001). Private communication to author see also http // www.vino.demon.co.uk/ppxrd/cefad.html. [303, 306f]... 

Another convention is the Patent Cooperation Treaty, to which the UK is a party along with members in both North and South America, Africa, Asia and the Pacific, as well as most of the EPC countries and other European countries. This facilitates making many national applications by filing in the single Patent Office. Thereafter, the individual national procedures operate independently, leading again to separate national patents. 

United Kingdom Patent Office, "European Directive (98/44/EC) on the Legal Protection of Biotechnological Inventions" (1998) (available www.patent.gov.uk). 

It is interesting to note that three different companies, ICI in the UK and 3M and Union Carbide in the USA, all independently developed routes to polyarylethersulphones, filing patents within less than a year from November 1962. Each chose different polymers for exploitation the structures chosen are shown in Table I. Inevitably with such close overlapping of inventions in the field, there was a clash of interest between Union Carbide, ICI and 3M in the patent area. This was resolved by the US Patent Office Board of Interference Examiners (see Record for Interference Nos. 95,807 and 95,808 pages 983 and 1139) in 1970 and their decision. 

United Kingdom Patent Office, www.patent.gov.uk (accessed August 9,2010). Information on intellectual property in the United Kingdom with a database to search patents and applications and current news in the United Kingdom. 

Palmer, R.M., Green, P.C., December 22, 2001. Energy Absorbing Material. Patent GB 0130834. Intellectual Property Office, UK. 

Traditionally, pharmaceutical companies are classified between a small number of big MNCs that do research and development (R D) for new drugs and aim to get these patented, and a large number of smaller generics companies that manufacture products that are not patented or products for which patents have expired. The MNCs are exceptionally large in size. The head offices are located in developed countries, mainly in the US, the UK, Switzerland, France, and Germany. They operate all over the world. The largest pharmaceutical MNC, Novartis (headquarters Basel, Switzerland) reported US 46 billion in pharmaceutical sales in 2013. Each of the other top five MNCs - Pfizer (US), Roche (Switzerland), Sanofi (France), Merck (US) and GlaxoSmithKline (UK) - individually had sales worth more than the entire pharmaceutical market of the Middle East and Africa in 2013. ... 

---